Clinical Trials Logo

Filter by:
NCT ID: NCT06144931 Recruiting - Pain, Postoperative Clinical Trials

Efficacy of Pericapsular Nerve Group (PENG) Block for Hip Surgeries

Start date: June 1, 2023
Phase: N/A
Study type: Interventional

To study the efficacy of the PENG block on the duration of postoperative analgesia. There are two groups of patients, who are undergoing hip joint surgeries, one group (Control Group) will receive spinal anesthesia only while the other group (PENG Group) will receive PENG block before spinal anesthesia.

NCT ID: NCT06144346 Recruiting - Breast Cancer Clinical Trials

Metastases Directed Therapy for Oligometastatic Breast Cancer

Start date: September 20, 2023
Phase: N/A
Study type: Interventional

This is a phase III randomized study evaluating the benefit from adding metastases directed therapy and locoregional treatment of the primary in breast cancer patients diagnosed with de novo oligometastatic disease patients will be randomized to receive the standard of care (SOC) treatment vs. systemic treatment + Stereotactic Ablative Radiation Therapy. Responders will be randomized to either undergo loco-regional management of the primary tumor or not

NCT ID: NCT06143930 Recruiting - MS Clinical Trials

Blood Flow Restriction Training in Multiple Sclerosis

Start date: July 1, 2023
Phase: N/A
Study type: Interventional

Traditional physical therapy resisted training for people with MS have been shown to be beneficial; however, their usefulness has been limited by fatigue. The effect of blood flow restriction on strength and other measures of physical function was demonstrated in healthy populations and those with chronic disease. This study may add missing information to the existing literature and suggests directions for research on the effectiveness of BFR training on individuals with relapsing and remitting MS.

NCT ID: NCT06142656 Recruiting - Clinical trials for Poly Cystic Ovary Syndrome

Efficacy of Vildagliptin Versus Metformin in Poly Cystic Ovary Syndrome

Start date: November 25, 2023
Phase: Phase 2/Phase 3
Study type: Interventional

Polycystic ovary syndrome (PCOS) is an endocrine disorder that affects approximately 10-20% of women of reproductive age, Management strategies for PCOS include lifestyle modifications such as diet and physical activity that are the first-line approach to treatment; however, they are reported to be minimally effective in reducing weight or treating PCOS-related symptoms.Pharmacological options are also available; however, they are not explicitly approved for PCOS treatment as they have been primarily used to treat other conditions such as T2DM

NCT ID: NCT06141915 Recruiting - Clinical trials for Immune System Disorder

Aerobic Training and Diet Protocol on Immune System in Burn Patients.

Start date: November 14, 2023
Phase: N/A
Study type: Interventional

Aerobic exercises can produce immediate and short-term improvements in the immune response of leukocytes, T-lymphocytes, lymphocyte subpopulations, interleukins, and immunoglobulins. Even only a single session of aerobic exercises produces improvements in the utmost immune markers, such as T-lymphocytes, leukocytes, and immunoglobulins. Also, burned patients suffer from post-traumatic stress and stress can cause this alteration through its effect on increasing the amounts of serum corticosteroid and catecholamine hormones, thus a decrease in the immunity response might occur. Increasing the aerobic capacity can significantly improve the mood. This might be attributed to the effect of aerobic exercises on decreasing stress hormones, like corticosteroids and catecholamines hormones. The altered metabolism post major burn also affects the immune system in burn patients and the aerobic training enhances the metabolism, body composition and the lean mass and so, enhances the immune system. One of the most important factors for a good and effective immune system is the balanced diet especially diet rich in vitamin D, fibers, and multiple nuts and seeds such as almond, walnut, pistachio, sunflower seeds, flax seeds and sesame seed that have an crucial role in improving the immune system either acting on it directly or indirectly by enhancing the general heath of the body and the patients mood.

NCT ID: NCT06141174 Recruiting - Pleural Infection Clinical Trials

Predictors of Outcome in Patients With Pleural Infection at Sohag University Hospital

Start date: November 1, 2023
Phase:
Study type: Observational

pleural infection remains a common medical problem with significant mortality and morbidity despite a better undrstanding of the aetiology , pathophysiology and recent advances in management approaches . the cornerstones of the managment op pleural infection include early identification of cases and accurate diagnosis . suitable antibiotic therapy , nutrition managment , efficient drainage of infected collection via chest tube with or without adjunctive therapies including intrapleural agents and ultimately surgical managment .

NCT ID: NCT06141161 Recruiting - Bronchial Asthma Clinical Trials

Assessment of Bronchial Asthma Among Patients Attending Sohag University Hospital

Start date: November 1, 2023
Phase:
Study type: Observational

Asthma is a significant public health threat, affecting more than 300 million individuals globally. Asthma is classified as a non-communicable disease and leads to reduced quality of life, poor physical functioning and reduced emotional well-being. The impact of this disease can be widespread and extends beyond the person living with the disease, affecting the lives of their family members, carers, communities and the health care system (1). Asthma is a variable chronic respiratory condition. It is characterized by symptoms of wheeze, cough, chest tightness, dyspnea and backed by variable airflow limitation, airway inflammation and airway hyper-responsiveness (AHR). The severity of asthma varies considerably, both between individuals and within individuals over time. Some people may have intermittent asthma and others may experience severe, potentially life-threatening disease (2, 3,4).

NCT ID: NCT06141148 Recruiting - Tuberculosis Clinical Trials

Clinical Presentation, and Treatment Outcomes in Tuberculous Patients in Sohag Governorate

Start date: November 1, 2023
Phase:
Study type: Observational

Tuberculosis (TB) is an infectious disease that commonly affects the lung and is caused by a bacterium called Mycobacterium Tuberculosis. The bacterium mostly affects people with impaired immunity TB becomes the second leading cause of morbidity and mortality among infectious diseases, following the emergence of the human immunodeficiency virus (HIV). HIV is the commonest risk factor for developing a life-threatening tuberculosis disease, on the other hand, HIV related immunodeficiency is worsened by TB infection.TB is among the top 10 causes of death worldwide. In2019, among 8.8 million adults who developed TB disease, 36% were women .TB has become the fifth leading cause of death among women.

NCT ID: NCT06140953 Recruiting - Clinical trials for Non-Alcoholic Fatty Liver Disease

Benefits of Trimetazidine in MAFLD Pateints

MAFLD
Start date: December 10, 2023
Phase: Phase 2
Study type: Interventional

Objective of this study is to determine the clinical benefits of trimetazidine in improvement of MAFLD

NCT ID: NCT06140849 Recruiting - Clinical trials for Artificial Intelligence

Evaluation of Artificial Intelligence Models for Diagnosis of Anterior Open Bite Malocclusion

Start date: November 2023
Phase:
Study type: Observational

Building artificial intelligence models for diagnosis of anterior open bite malocclusion